Global Gene Therapy Medicine Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gene Therapy Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Oral
  • 1.2.3 Injection
• 1.3 Market by Application
  • 1.3.1 Global Gene Therapy Medicine Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Cancer
  • 1.3.3 Monogenic
  • 1.3.4 Infectious Disease
  • 1.3.5 Cardiovascular Disease
  • 1.3.6 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gene Therapy Medicine Market Perspective (2016-2027)
• 2.2 Gene Therapy Medicine Growth Trends by Regions
  • 2.2.1 Gene Therapy Medicine Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Gene Therapy Medicine Historic Market Share by Regions (2016-2021)
  • 2.2.3 Gene Therapy Medicine Forecasted Market Size by Regions (2022-2027)
• 2.3 Gene Therapy Medicine Industry Dynamic
  • 2.3.1 Gene Therapy Medicine Market Trends
  • 2.3.2 Gene Therapy Medicine Market Drivers
  • 2.3.3 Gene Therapy Medicine Market Challenges
  • 2.3.4 Gene Therapy Medicine Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gene Therapy Medicine Players by Revenue
  • 3.1.1 Global Top Gene Therapy Medicine Players by Revenue (2016-2021)
  • 3.1.2 Global Gene Therapy Medicine Revenue Market Share by Players (2016-2021)
• 3.2 Global Gene Therapy Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Gene Therapy Medicine Revenue
• 3.4 Global Gene Therapy Medicine Market Concentration Ratio
  • 3.4.1 Global Gene Therapy Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicine Revenue in 2020
• 3.5 Gene Therapy Medicine Key Players Head office and Area Served
• 3.6 Key Players Gene Therapy Medicine Product Solution and Service
• 3.7 Date of Enter into Gene Therapy Medicine Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Medicine Breakdown Data by Type

• 4.1 Global Gene Therapy Medicine Historic Market Size by Type (2016-2021)
• 4.2 Global Gene Therapy Medicine Forecasted Market Size by Type (2022-2027)

5 Gene Therapy Medicine Breakdown Data by Application

• 5.1 Global Gene Therapy Medicine Historic Market Size by Application (2016-2021)
• 5.2 Global Gene Therapy Medicine Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Gene Therapy Medicine Market Size (2016-2027)
• 6.2 North America Gene Therapy Medicine Market Size by Type
  • 6.2.1 North America Gene Therapy Medicine Market Size by Type (2016-2021)
  • 6.2.2 North America Gene Therapy Medicine Market Size by Type (2022-2027)
  • 6.2.3 North America Gene Therapy Medicine Market Size by Type (2016-2027)
• 6.3 North America Gene Therapy Medicine Market Size by Application
  • 6.3.1 North America Gene Therapy Medicine Market Size by Application (2016-2021)
  • 6.3.2 North America Gene Therapy Medicine Market Size by Application (2022-2027)
  • 6.3.3 North America Gene Therapy Medicine Market Size by Application (2016-2027)
• 6.4 North America Gene Therapy Medicine Market Size by Country
  • 6.4.1 North America Gene Therapy Medicine Market Size by Country (2016-2021)
  • 6.4.2 North America Gene Therapy Medicine Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Gene Therapy Medicine Market Size (2016-2027)
• 7.2 Europe Gene Therapy Medicine Market Size by Type
  • 7.2.1 Europe Gene Therapy Medicine Market Size by Type (2016-2021)
  • 7.2.2 Europe Gene Therapy Medicine Market Size by Type (2022-2027)
  • 7.2.3 Europe Gene Therapy Medicine Market Size by Type (2016-2027)
• 7.3 Europe Gene Therapy Medicine Market Size by Application
  • 7.3.1 Europe Gene Therapy Medicine Market Size by Application (2016-2021)
  • 7.3.2 Europe Gene Therapy Medicine Market Size by Application (2022-2027)
  • 7.3.3 Europe Gene Therapy Medicine Market Size by Application (2016-2027)
• 7.4 Europe Gene Therapy Medicine Market Size by Country
  • 7.4.1 Europe Gene Therapy Medicine Market Size by Country (2016-2021)
  • 7.4.2 Europe Gene Therapy Medicine Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Therapy Medicine Market Size (2016-2027)
• 8.2 Asia-Pacific Gene Therapy Medicine Market Size by Type
  • 8.2.1 Asia-Pacific Gene Therapy Medicine Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Gene Therapy Medicine Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Gene Therapy Medicine Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Gene Therapy Medicine Market Size by Application
  • 8.3.1 Asia-Pacific Gene Therapy Medicine Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Gene Therapy Medicine Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Gene Therapy Medicine Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Gene Therapy Medicine Market Size by Region
  • 8.4.1 Asia-Pacific Gene Therapy Medicine Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Gene Therapy Medicine Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Gene Therapy Medicine Market Size (2016-2027)
• 9.2 Latin America Gene Therapy Medicine Market Size by Type
  • 9.2.1 Latin America Gene Therapy Medicine Market Size by Type (2016-2021)
  • 9.2.2 Latin America Gene Therapy Medicine Market Size by Type (2022-2027)
  • 9.2.3 Latin America Gene Therapy Medicine Market Size by Type (2016-2027)
• 9.3 Latin America Gene Therapy Medicine Market Size by Application
  • 9.3.1 Latin America Gene Therapy Medicine Market Size by Application (2016-2021)
  • 9.3.2 Latin America Gene Therapy Medicine Market Size by Application (2022-2027)
  • 9.3.3 Latin America Gene Therapy Medicine Market Size by Application (2016-2027)
• 9.4 Latin America Gene Therapy Medicine Market Size by Country
  • 9.4.1 Latin America Gene Therapy Medicine Market Size by Country (2016-2021)
  • 9.4.2 Latin America Gene Therapy Medicine Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Therapy Medicine Market Size (2016-2027)
• 10.2 Middle East & Africa Gene Therapy Medicine Market Size by Type
  • 10.2.1 Middle East & Africa Gene Therapy Medicine Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Gene Therapy Medicine Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Gene Therapy Medicine Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Gene Therapy Medicine Market Size by Application
  • 10.3.1 Middle East & Africa Gene Therapy Medicine Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Gene Therapy Medicine Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Gene Therapy Medicine Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Gene Therapy Medicine Market Size by Country
  • 10.4.1 Middle East & Africa Gene Therapy Medicine Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Gene Therapy Medicine Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Bluebird Bio
  • 11.1.1 Bluebird Bio Company Details
  • 11.1.2 Bluebird Bio Business Overview
  • 11.1.3 Bluebird Bio Gene Therapy Medicine Introduction
  • 11.1.4 Bluebird Bio Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.1.5 Bluebird Bio Recent Development
• 11.2 Sangamo
  • 11.2.1 Sangamo Company Details
  • 11.2.2 Sangamo Business Overview
  • 11.2.3 Sangamo Gene Therapy Medicine Introduction
  • 11.2.4 Sangamo Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.2.5 Sangamo Recent Development
• 11.3 Spark Therapeutics
  • 11.3.1 Spark Therapeutics Company Details
  • 11.3.2 Spark Therapeutics Business Overview
  • 11.3.3 Spark Therapeutics Gene Therapy Medicine Introduction
  • 11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.3.5 Spark Therapeutics Recent Development
• 11.4 Dimension Therapeutics
  • 11.4.1 Dimension Therapeutics Company Details
  • 11.4.2 Dimension Therapeutics Business Overview
  • 11.4.3 Dimension Therapeutics Gene Therapy Medicine Introduction
  • 11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.4.5 Dimension Therapeutics Recent Development
• 11.5 Avalanche Bio
  • 11.5.1 Avalanche Bio Company Details
  • 11.5.2 Avalanche Bio Business Overview
  • 11.5.3 Avalanche Bio Gene Therapy Medicine Introduction
  • 11.5.4 Avalanche Bio Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.5.5 Avalanche Bio Recent Development
• 11.6 Celladon
  • 11.6.1 Celladon Company Details
  • 11.6.2 Celladon Business Overview
  • 11.6.3 Celladon Gene Therapy Medicine Introduction
  • 11.6.4 Celladon Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.6.5 Celladon Recent Development
• 11.7 Vical Inc.
  • 11.7.1 Vical Inc. Company Details
  • 11.7.2 Vical Inc. Business Overview
  • 11.7.3 Vical Inc. Gene Therapy Medicine Introduction
  • 11.7.4 Vical Inc. Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.7.5 Vical Inc. Recent Development
• 11.8 Advantagene
  • 11.8.1 Advantagene Company Details
  • 11.8.2 Advantagene Business Overview
  • 11.8.3 Advantagene Gene Therapy Medicine Introduction
  • 11.8.4 Advantagene Revenue in Gene Therapy Medicine Business (2016-2021)
  • 11.8.5 Advantagene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer